HIV
Kenya has received a Sh256 million ($2 million) grant from the Global Fund to support the nationwide distribution of Lenacapavir, a new HIV prevention injection. The initiative, launched in Nairobi, represents a shift from daily oral medication to a twice-yearly injectable. Lenacapavir Implementation The grant will focus on service delivery, healthcare worker training, and community […]
Kenya has begun a new phase in its HIV prevention strategy with the introduction of Lenacapavir, a long-acting injectable pre-exposure prophylaxis (PrEP). The initiative, confirmed on February 17, 2026, marks Kenya as the first East African nation to implement this advanced prevention option. The rollout is a collaboration between the Ministry of Health and the […]
Kenya has initiated a phased rollout of Lenacapavir, a long-acting injectable medicine for HIV prevention. The government’s action marks a significant advancement in the nation’s public health strategy and places Kenya among nine African countries pioneering this innovation. The introduction of Lenacapavir aims to address challenges associated with daily oral pre-exposure prophylaxis (PrEP), including stigma […]
-
Pages